International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Patsalos Prize

Awarded for Best Therapeutic Drug Monitoring Journal Manuscript

Professor Philip Patsalos and his wife Ellie, London, UK, set up the Patsalos Prize for the best TDM manuscript published in Therapeutic Drug Monitoring in a given two year calendar period and which will be awarded at the IATDMCT Congress.

Terms of Reference

Award of Prize
The Prize will be awarded at the IATDMCT Congress for a 5-year period (2019, 2021, 2023, 2025, 2027).  
The prize may not be awarded at each Congress if a quality manuscript cannot be identified.

This award is presented every two years, at the Congress ODD years (2021, 2023, 2025, etc.).

Selection Committee

  • IATDMCT President (Chair)
  • Editor-in-Chiefs (Therapeutic Drug Monitoring)
  • President-elect

Procedure for manuscript nomination and selection of winner

  1. The Editor-in-Chief will first identify potential eligible manuscripts and make a proposal to the chairperson.
    Selection criteria are: originality, conclusiveness, study design and performance, impact on science and practice (enhancing patient treatment/care), impact on future developments, global importance, etc.
  2. The chairperson will check whether the first author (to whom the Prize will be awarded) is an active member of IATDMCT.
  3. The chairperson will prepare a list of all eligible manuscripts and distribute the list to members of the Selection Committee for their consideration.
  4. By conference call, a winner will be selected by "simple majority".

Which manuscripts are eligible for nomination

  • Full length original research manuscripts published during the two previous years of the year the prize is going to be awarded
    (i.e. for the prize awarded in 2019, papers published in 2017 and 2018 will be considered).
  • Said manuscripts will have made exceptional ontribution towards advancing knowledge in the field of TDM.

The selection procedure will start in the congress year and as soon as possible after the publication of the December issue of Therapeutic Drug Monitoring of the year before.

5.000€ plus an invitation to make a short presentation (Patsalos Lecture) at the Opening Ceremonies of the IATDMCT Congress. In addition, IATDMCT offers a two-year free membership, anticipating active contributions to IATDMCT by the recipient.

Sponsored by

Philip & Ellie Patsalos

patsalos prize

Past Recipients

  • 2019 Kristine Hole, Norway
    for the paper:
    Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker
    by Hole, Kristine MSc; Wollmann, Birgit M. MSc; Nguyen, Camilla MSc; Haslemo, Tore PhD; Molden, Espen PhD
    Published in Therapeutic Drug Monitoring, Volume 40, Number 4, August 2018, p 463-468
  • 2017 Michael Neely, USA
    for the paper:
    Accurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software
    by Neely, Michael MD; Philippe, Michael MSc; Rushing, Teresa PharmD; Fu, Xiaowei PhD; van Guilder, Michael PhD; Bayard, David PhD; Schumitzky, Alan PhD; Bleyzac, Nathalie PharmD, PhD; Goutelle, Sylvain PharmD, PhD
    Published in Therapeutic Drug Monitoring, Volume 38, Number 3, June 2016, p 332-342
  • 2015 Laure Elens, Belgium
    for the paper:
    Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal Transplantation: Toward Updated Genotype-Based Dosage Guidelines
    by Elens, Laure PhD; Capron, Arnaud PhD; van Schaik, Ron HN; De Meyer, Martine MD; De Pauw, Luc MD; Eddour, Djamila C.; Latinne, Dominique MD, PhD; Wallemacq, Pierre PharmD, PhD; Mourad, Michel MD, PhD; Haufroid, Vincent PharmD, PhD
    Published in Therapeutic Drug Monitoring, Volume 35, Number 5, October 2013, p 608-616
  • 2013 Franck Saint-Marcoux, France
    for the paper:
    Development and Evaluation of a Simulation Procedure to Take Into Account Various Assays for the Bayesian Dose Adjustment of Tacrolimus
    by Saint-Marcoux, Franck PhD, PharmD; Debord, Jean MD, PhD; Parant, François PharmD, PhD; Labalette, Myriam MD, PhD; Kamar, Nassim MD, PhD; Rostaing, Lionel MD, PhD; Rousseau, Annick PhD; Marquet, Pierre
    Published in Therapeutic Drug Monitoring, Volume 33, Number 2, April 2011, p 171-177
  • 2011 Karl B. Scheidweiler, USA
    for the paper:
    Pharmacokinetics of Cocaine and Metabolites in Human Oral Fluid and Correlation With Plasma Concentrations After Controlled Administration
    by Scheidweiler KB, Spargo EA, Kelly TL, Cone EJ, Barnes AJ, Huestis MA
    Published in Therapeutic Drug Monitoring, Volume 32, Number 5, October 2010, p 628-637
  • 2009 Nils Tore Vethe, Norway
    for the paper:
    Pharmacodynamics of Mycophenolic Acid in CD4+ Cells: A Single-Dose Study of IMPDH and Purine Nucleotide Responses in Healthy Individuals
    by Vethe, Nils Tore MScPharm; Bremer, Sara MScPharm; Rootwelt, Helge MD, PhD; Bergan, Stein PhD
    Published in Therapeutic Drug Monitoring, Volume 30, Number 6, December 2008, p 647-655

Deadline: April 30, 2021 Nominations must be received by April 15 of the Congress year in ODD years (2021, 2023, 2025, etc.).


Contact Us
IATDMCT Awards Committee